A CE-IVD certified rapid test platform that enables fully automated quantification of up to 8 (or 16) biomarkers in parallel from capillary blood or other specimens. The system combines accelerated hybridization through novel microfluidics technology with chemiluminescence-based optical detection an...
Manufactured by
Rainbach im Muehlkreis, Austria
GENSPEED Biotech GmbH – Rapid Multiplex Diagnostics in Laboratory Quality GENSPEED Biotech develops and manufactures rapid diagnostic tests that combine laboratory accuracy with true point-of-care convenience . Our proprietary GENSPEED® Multiplex Micro-ELISA Platform delivers quantitative, lab-quality results within 15–20 minutes from a single drop of capillary blood or other biological samples. The technology integrates microfluidics, chemiluminescence detection, and multiplexed ELISA chemistry in a compact, cartridge-based format. It enables simultaneous quantification of up to eight biomarkers, providing comprehensive diagnostic insights directly at the point of need — in pharmacies, doctors offices, clinics, and research laboratories. GENSPEED is IVDR-certified and already offers CE-marked assays such as the Vitamin D xPOC , FSME (TBE) IgG xPOC , COVID-19 IgG xPOC , and PerioPOC Pro tests. Current developments include multiplex assays for prosthetic joint infection (PJI) , process analytical testing for biopharmaceutical manufacturing (HEK293 HCP assay) and other applications. Our vision is to bring laboratory diagnostics to the point of care – enabling faster, data-driven medical decisions that improve patient outcomes and strengthen healthcare accessibility.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Sciverse Solutions
India · 2 relevant products
Response Biomedical
Canada · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
Xenta Biomedical Science Co.,Ltd
China · 2 relevant products
Biocare Medical
United States · 1 relevant product
Shenzhen YHLO Biotech Co., Ltd.
China · 2 relevant products
Cambrian Bioworks LLC
United States · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 1 relevant product
29 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 45 closest product alternatives
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Sciverse Solutions · India
A portable molecular diagnostics system featuring a disposable microfluidic cartridge for closed-system nucleic acid testing with zero cross-contamination. The platform supports up to 32-plex multiplexing, delivers results in 45 minutes, and is available in handheld and benchtop configurations with customizable assays including a ready-to-deploy COVID-19 panel.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.
Xenta Biomedical Science Co.,Ltd · China
An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.
Biocare Medical · United States
Advanced multiplex immunohistochemistry detection system enabling simultaneous staining with multiple antibodies on a single slide. Reduces turnaround time and simplifies laboratory procedures.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
Cambrian Bioworks LLC · United States
Automated platform for molecular diagnostics of infectious pathogens. Integrates nucleic acid extraction and amplification for rapid disease identification.
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
ZIODIA Co., Ltd. · South Korea
A diagnostic device platform based on MEMS (Micro-Electro-Mechanical System) core technology that enables precise control and detection of minute whole blood samples and implements real-time analysis at the point-of-care level through Lab-on-a-Chip technology. The platform is designed for medical chain diagnosis devices and related solutions.
Verge HealthTech Fund · Singapore
Laser-based diagnostic platform designed for rapid, multiplexed lateral flow testing with significantly reduced manufacturing costs. The technology provides sensitive and scalable point-of-care diagnostic capabilities for various clinical applications.
33 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products